Discrepancy between Angina and Ischemia Repeats in Peripheral Artery Disease

Three randomized studies showed exercising significantly improves 6-minute walk outcomes in patients with peripheral artery disease (PAD). However, many participants randomized to exercise did not perceive changes, and sometimes even got worse. 

La discrepancia entre angina e isquemia se repiten en enfermedad periférica

These findings suggest a significant discrepancy between objective and perceived change in walking ability among PAD patients.  

400 patients with peripheral artery disease randomized to exercise (n=205) vs control (n=199) completed a 6-minute walk test and a questionnaire about perceived claudication. Both tests were repeated 6 months after randomization.

Exercising improved significantly 6-minute walking distance almost 40 meters vs. baseline (p<0.001). 

Many patients perceived no improvement in walking ability after 6 months. This was true for the control group, with – 6.5 meters vs baseline (p<0.001), as opposed to the exercise group, which added 26.8 meters (p<0.001).

Another group perceived their situation had significantly worsened vs. baseline. Again, this was true for the control group, with – 27.3 meters, but not for the exercise group, with + 18.4 meters vs. baseline. 


Read also: Abdominal Aortic Aneurysm during the Pandemic: Should They Be Operated or Deferred?


Having set a walking pace, PAD patients will often report no improvement at follow up, which might tilt the scales for revascularization. It seems important to be able to objectively measure walking ability at baseline and follow up to be able to make objective decisions. 

The coronaries have shown angina and ischemia do not walk hand in hand. Now peripheral vascular disease shows similar discrepancy between symptoms and objective test outcomes. 

Conclusion

Exercising significantly improves walking distance in PAD patients. However, many patients do not perceive this change, and some even feel they get worse. 

JAHA-120-017609

Original Title: Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy.

Reference: Mary M. McDermott et al. J Am Heart Assoc. 2021;10:e017609. DOI: 10.1161/JAHA.120.017609.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....